1. Home
  2. NNNN vs PAR Comparison

NNNN vs PAR Comparison

Compare NNNN & PAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNNN
  • PAR
  • Stock Information
  • Founded
  • NNNN 2021
  • PAR 1968
  • Country
  • NNNN Germany
  • PAR United States
  • Employees
  • NNNN N/A
  • PAR N/A
  • Industry
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • PAR Office Equipment/Supplies/Services
  • Sector
  • NNNN Health Care
  • PAR Miscellaneous
  • Exchange
  • NNNN Nasdaq
  • PAR Nasdaq
  • Market Cap
  • NNNN 2.2B
  • PAR 2.4B
  • IPO Year
  • NNNN 2025
  • PAR N/A
  • Fundamental
  • Price
  • NNNN $45.65
  • PAR $49.28
  • Analyst Decision
  • NNNN
  • PAR Strong Buy
  • Analyst Count
  • NNNN 0
  • PAR 7
  • Target Price
  • NNNN N/A
  • PAR $78.43
  • AVG Volume (30 Days)
  • NNNN 88.1K
  • PAR 1.1M
  • Earning Date
  • NNNN 01-01-0001
  • PAR 08-08-2025
  • Dividend Yield
  • NNNN N/A
  • PAR N/A
  • EPS Growth
  • NNNN N/A
  • PAR N/A
  • EPS
  • NNNN 0.06
  • PAR N/A
  • Revenue
  • NNNN $8,185,146.00
  • PAR $418,022,000.00
  • Revenue This Year
  • NNNN N/A
  • PAR $28.96
  • Revenue Next Year
  • NNNN N/A
  • PAR $14.59
  • P/E Ratio
  • NNNN $839.78
  • PAR N/A
  • Revenue Growth
  • NNNN 21.95
  • PAR 45.74
  • 52 Week Low
  • NNNN $5.18
  • PAR $46.24
  • 52 Week High
  • NNNN $55.65
  • PAR $82.24
  • Technical
  • Relative Strength Index (RSI)
  • NNNN N/A
  • PAR 34.28
  • Support Level
  • NNNN N/A
  • PAR $50.75
  • Resistance Level
  • NNNN N/A
  • PAR $53.24
  • Average True Range (ATR)
  • NNNN 0.00
  • PAR 1.82
  • MACD
  • NNNN 0.00
  • PAR 0.36
  • Stochastic Oscillator
  • NNNN 0.00
  • PAR 3.87

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

About PAR PAR Technology Corporation

PAR Technology Corp is a foodservice technology company providing omnichannel cloud-based software and hardware solutions to the restaurant industry in three restaurant categories - quick service, fast casual, and table service - and the retail industry, including convenience and fuel retailers (C-Stores). The company's product and service offerings include point-of-sale, customer engagement and loyalty, digital ordering and delivery, operational intelligence, payment processing, hardware, and related technologies, solutions, and services. The company generates revenue from subscription service, Sale of Hardware products, and Professional Service.

Share on Social Networks: